CADTH.ca

Begin main content

Want to browse reports and resources on high-interest topics? Visit our Evidence Bundles.

Featured Reports

Dementia Villages

As the population ages, decision-makers are faced with different choices of care models for people diagnosed with dementia. Recent media ...

Last updated: October 24, 2019

dolutegravir / lamivudine

Last updated: October 23, 2019

Internet-Delivered Cognitive Behavioural Therapy for Major Depressive Disorder and Anxiety Disorders: A Health Technology Assessment

Major depressive disorder (MDD) is the occurrence of one or more major depressive episodes that last at least two weeks. Anxiety disorder...

Last updated: November 8, 2019

View all Reports

Upcoming Events

CADTH Medical Device and Drug Portfolio Information Sessions

These sessions will be presented in English and are available in person or via live broadcast. There is no charge to attend, but advance ...

Event Date: November 25, 2019

Evidence-to-Action: Accessing Mental Health Support Outside of a Therapist’s Office: iCBT for Major Depression and Anxiety Disorders

Internet-delivered cognitive behavioural therapy (iCBT) is a treatment option for people living with depression or anxiety disorders. Thi...

Event Date: November 27, 2019

2020 CADTH Symposium

Join us in Toronto for the 2020 CADTH Symposium. Connect with Canadian and international experts in the objective assessment and evaluat...

Event Date: April 19, 2020 - April 21, 2020

View all Events

News Feed

New at CADTH - November 2019

Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news ...

Published on: November 7, 2019

Drug Reimbursement Recommendation - Idhifa and Vitrakvi

Today, CADTH has issued final recommendations for: Enasidenib (Idhifa) for Acute Myeloid Leukemia Funding Request: For the treatment of...

Published on: October 31, 2019

Drug Reimbursement Recommendation - Xultophy

Today, CADTH has issued final recommendations for: insulin degludec + liraglutide (Xultophy) Indications: Diabetes mellitus, Type 2 Rec...

Published on: October 28, 2019

View all News